Early identification of pancreaticoduodenal endocrine tumors (PETs) in multiple endocrine
neoplasia type 1 (MEN-1) is mandatory, because these tumors represent the most common …

Background Patients with multiple endocrine neoplasia (MEN) type 1 risk premature death
from pancreatic endocrine tumours (PETs). Endoscopic ultrasonography (EUS) is the most …

Objective: To evaluate the outcome of an aggressive surgical approach for
duodenopancreatic neuroendocrine tumors (PETs) associated with multiple endocrine …

Background Many serologic and radiographic modalities are used for monitoring multiple
endocrine neoplasia type 1 (MEN 1) patients for pancreaticoduodenal neuroendocrine …

Background. The management of pancreaticoduodenal endocrine tumors (PETs) remains
controversial in multiple endocrine neoplasia type 1 (MEN 1). Methods. Twenty-one patients …

Aim: To assess presentation and outcome of pancreaticoduodenal endocrine tumors
(PDETs) in a single center series of multiple endocrine neoplasia type 1 (MEN1) patients …

Prospective Endoscopic Ultrasonographic Evaluation of the Fr... : Official journal of the
American College of Gastroenterology | ACG Prospective Endoscopic Ultrasonographic …

Background: Neuroendocrine tumors (NETs) are a potentially lethal component of multiple
endocrine neoplasia type 1 (MEN 1). Somatostatin receptor scintigraphy (SRS) can be used …

BACKGROUND: EUS is highly sensitive, specific, and cost-effective for localization of
pancreatic neuroendocrine tumors. EUS screening of asymptomatic patients with multiple …

OBJECTIVE: In multiple endocrine neoplasia type 1, the main risk factor for metastases is
pancreatic tumour size. We and others recommend limiting surgery to non-functioning …